Role of Drugs in COVID 19 Patient: A Review

Avni Bhatia *

Deptartment of Community Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (Deemed to be University), Sawangi (Meghe), Wardha-442001, Maharashtra, India.

*Author to whom correspondence should be addressed.


Abstract

Background: No specific drug treatment is available for the COVID-19. Various drugs are being used and repurposed as COVID-19 treatment.

Summary: COVID-19 has no defined treatment course because it has no precedent. Various drugs are tried and tested to be used upon patients to treat particular symptom. Hydroxycholoroquine, lopinavir, ritonavir and so on are the famous drugs being repurposed as COVID-19 treatment drugs. Prophylactics are not widely listed but supplements and drugs which contain anti-inflammatory properties and anti-oxidants should be inculcated in the diet so that innate immune response can fight off the external pathogenic invasion all by itself.

Conclusion: Drugs listed for repurposing method must be tried and tested before administered it to a severely ill patients or to a large chunk of population. Proper study needs to be done before administered and starting full-fledged usage of any existing drug not meant for the treatment of COVID-19.

Keywords: Covid-19 treatment drugs, pandemic covid-19, drugs properties


How to Cite

Bhatia, A. (2021) “Role of Drugs in COVID 19 Patient: A Review”, Journal of Pharmaceutical Research International, 33(36A), pp. 99–105. doi: 10.9734/jpri/2021/v33i36A31931.